Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel
Teva settles opioid lawsuit with Oklahoma for $85 million - MarketWatch
Teva worked with other drug firms to inflate prices, lawsuit claims - Axios
Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York Times
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
Teva's generic label not skinny enough to protect from $234M damages to GSK - MedCity News
Teva to pay Oklahoma $85 million in opioid lawsuit - Business - Haaretz.com
Teva at the center of a lawsuit for raising drug prices - The Jerusalem Post
Teva sues two Indian generics over Huntington's treatment
J&J, Teva and Other Opioid Drugmakers Face $50 Billion Lawsuit in California | BioSpace
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
Trial set to open in massive US opioid lawsuit also targeting Israel's Teva | The Times of Israel
J&J, Teva offer a whopping $48B combined to wrap opioid suits, but not all plaintiffs are on board | FiercePharma
IN BRIEF: Teva to pay $1.1 mln in Intuniv antitrust settlement | Reuters
Trouble at Teva: US price-fixing lawsuit adds to generic giant's woes - Pharma Technology Focus | Issue 85 | August 2019
Teva shares tumble as company faces price-fixing lawsuit - The Jerusalem Post
Teva Stock Pressured From Antitrust Lawsuit Against Drug Makers | Barron's
Teva Sued by U.S. Over Claims of Copaxone Medicare Fraud - Bloomberg
New York jury holds drug firm Teva liable in opioid crisis
Generic Drug Lawsuit Could Mean Big Fines for Teva, Mylan: UBS
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva Stock Climbs as CEO Says Opioid Settlement Could Come Within a Year | Barron's
Teva Pharmaceuticals - Wikipedia
